Treatments for sustained response in Alzheimer's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether a treatment (atomoxetine or metformin) can help people with Alzheimer's disease maintain an improved state for at least 18 months. It may help you or a loved one stabilize symptoms and slow disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 or older (no upper age limit)
- You have a diagnosis of Alzheimer's disease or mixed Alzheimer's and vascular dementia
- A blood test or brain scan shows signs of Alzheimer's inside your body
- Your memory and thinking are still fairly good (score of 17 or higher on a special test)
- You can safely have an MRI brain scan (no metal implants or severe anxiety in scanners)
- You have a caregiver or family member who can join study visits with you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This study tests an oral medication that may change how the body processes energy to help people with early Alzheimer's disease. It aims to see if the treatment can slow down memory loss and improve daily function.
This trial tests a special supplement combination designed to support brain energy use in people with Alzheimer's. It aims to see if the supplement can help slow cognitive decline.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study tests whether a daily pill (tadalafil, a type of medicine usually used for blood pressure or erectile dysfunction) can help people with early Alzheimer's or mild memory problems. It aims to see if this drug can improve memory and slow down the disease, with the help of regular checkups and brain scans.
Hear when a new Alzheimer's Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.